Hutch News

Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita

Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita

Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists
Hutch NewsJanuary 30, 2026
The benefits of HIV research? Let us count the ways

The benefits of HIV research? Let us count the ways

HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts
Hutch NewsNovember 28, 2025
CD16+ monocytes are the first responders to HIV reactivation

CD16+ monocytes are the first responders to HIV reactivation

From the Cohn Lab, Vaccine and Infectious Disease Division
Science SpotlightNovember 19, 2025
Viruses are linked to lung disease in hematopoietic cell transplant recipients

Viruses are linked to lung disease in hematopoietic cell transplant recipients

From the Boeckh Lab, Vaccine and Infectious Disease and Clinical Research Divisions
Science SpotlightNovember 19, 2025
Viral immunologist taps ‘incredible potential’ of immune system

Viral immunologist taps ‘incredible potential’ of immune system

Dr. Paul Thomas will combine computational and empirical approaches to understand the immune repertoire and turn this knowledge into new diagnostic and therapeutic tools
Hutch NewsNovember 05, 2025
HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases

HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases

Numerous medical advances originate from U.S.-funded HIV research
News ReleasesOctober 27, 2025
Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients

Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients

More than 6% of Americans are immunocompromised, yet most clinical trials exclude them
News ReleasesSeptember 23, 2025
HIV reservoir decay rates defined for children receiving ART

HIV reservoir decay rates defined for children receiving ART

From Dr. Daniel Reeves and colleagues, Fred Hutch Vaccine & Infectious Disease Division and UW Global Health
Science SpotlightAugust 29, 2025
New horizons in infectious disease treatment and prevention in immunocompromised patients

New horizons in infectious disease treatment and prevention in immunocompromised patients

The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
Hutch NewsJune 23, 2025
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees

Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees

Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
News ReleasesJune 16, 2025
Cytomegalovirus has an activity shift following CAR T-cell therapy

Cytomegalovirus has an activity shift following CAR T-cell therapy

From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
Science SpotlightMay 26, 2025
New insights into T cell function in multiple myeloma patients

New insights into T cell function in multiple myeloma patients

From the Newell Lab, Vaccine and Infectious Disease Division
Science SpotlightMay 26, 2025
Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science

Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science

Award recognizes leadership in HIV vaccine trial development, analysis
Hutch NewsMay 09, 2025
Managing mountains of genomic data

Managing mountains of genomic data

Tools invented at Fred Hutch are helping researchers analyze the enormous global database of genomic sequences of the virus that causes COVID-19 to better understand how pathogens evolve and spread
Hutch NewsApril 22, 2025